Author's reply to uses of clopidogrel, rosuvastatin and digoxin on the risk of acute pancreatitis.
College of Medicine, China Medical University, Taichung, Taiwan; Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan.
Shih-Wei
SW
Lai
College of Medicine, China Medical University, Taichung, Taiwan; Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan.
Cheng-Li
CL
Lin
Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan; Department of Internal Medicine, Taichung Tzu Chi General Hospital, Taichung, Taiwan. Electronic address: kuanfuliaog@gmail.com.
Kuan-Fu
KF
Liao
D005260:Female; D006801:Humans; D008297:Male; D010195:Pancreatitis / Q000453:epidemiology*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D013988:Ticlopidine / Q000031:analogs & derivatives*
D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine
Acute pancreatitis; Clopidogrel; Digoxin; Rosuvastatin